Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T21:10:38.730Z Has data issue: false hasContentIssue false
  • English
  • Français

Amyotrophic Lateral Sclerosis: Concepts in Pathogenesis and Etiology

Published online by Cambridge University Press:  18 September 2015

Andrew A. Eisen  and
Arthur J. Hudson
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The ALS symposium in Vancouver was the first of its kind in Canada and was a contribution from both American and Canadian investigators. The main points presented were (1) a definition of what is truly ALS, in the clinical and pathological sense, based on what is called “classical” ALS; (2) how neurons may be cultured to provide a valuable experimental tool; (3) the significance of lipid abnormalities in ALS and the characterization of the ALS-like syndromes produced by hexosaminidase A deficiency; (4) the possible role of autoimmune disease as it may accompany classical ALS and nerve growth factor derived from skeletal muscle; (5) the western Pacific form of ALS as it has been intensely studied and has given rise to two hypotheses on pathogenesis: mineral toxicity caused by secondary hyperparathyroidism and poisoning through ingestion of the cycad seed, and (6) the possible abiotropic interaction of one or many environmental toxins over a lifetime with the aging nervous system, depleting it of its frail reserve of neurons.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 14 , Issue 4 , November 1987 , pp. 649 - 652
Copyright
Copyright © Canadian Neurological Sciences Federation 1987

References

1.Hudson, AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217–247.CrossRefGoogle ScholarPubMed
2.Hudson, AJ, Vinters, HV, Povey, RC, Hatch, LA, Percy, DH, Noseworthy, JH, Kaufmann, JCE. An unusual form of motor neuron disease following a cat bite. Can J Neurol Sci 1986; 13: 111–116.CrossRefGoogle ScholarPubMed
3.Cashman, NR, Antel, JP, Hancock, LW, Dawson, G, Horwitz, AL, Johnson, WG, Huttenlocher, PR, Wollmann, RL. N-acetyl-β-hexosaminidase β locus defect and juvenile motor neuron disease: a case study. Ann Neurol 1986; 19: 568–572.CrossRefGoogle ScholarPubMed
4.Yaffe, MG, Kaback, M, Goldberg, M, Miles, J, Itabashi, H, Mclntyre, H, Mohandas, T. An amyotrophic lateral sclerosis-like syndrome with hexosaminidase-α deficiency: A new type of GM2-ganglio-sidosis. Neurology 1979; 29: 611 A.Google Scholar
5.Johnson, WG. Hexosaminidase deficiency: A cause of recessively inherited motor neuron diseases. In: Rowland, LP, ed. Human Motor Neuron Diseases. Advances in Neurology. New York: Raven Press 1982; 36: 159–164.Google Scholar
6.Hauser, SL, Cazenave, P-A, Lyon-Caen, O, Tagushi, T, Huchet, M, Nuret, H, Changeux, J-P, Henderson, CE. Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurological diseases. Neurology 1986; 36: 1614–1618.CrossRefGoogle Scholar
7.Antel, JP, Noronha, ABC, Oger, JJ-F, Arnason, BGW. Immunology of amyotrophic lateral sclerosis. In: Rowland, LP, ed. Human Motor Neuron Diseases. Advances in Neurology. New York: Raven Press 1982; 36: 395–402.Google Scholar
8.Roisen, FJ, Donnenfield, H, Vartfeld, H, Baxter, J. Circulating neurotoxins in amyotrophic lateral sclerosis. In: Rowland, LP, ed. Human Motor Neuron Diseases. Advances in Neurology. New York: Raven Press 1982; 36: 403–417.Google Scholar
9.Gurney, ME, Belton, AC, Cashman, N, Antel, JP. Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. New Eng J Med 1984; 311: 933–939.CrossRefGoogle ScholarPubMed
10.Kim, SU, Osborne, DN, Kim, MW, et al. Long-term culture of human spinal neurons: Morphological, immunocytochemical and electrophysiological characteristics. (In preparation.)Google Scholar
11.Puil, E, Spigelman, I, Eisen, A, Kim, SU. Electrophysiological responses of human spinal neurons in culture. Neuroscience Letters 1986; 71: 77–82.CrossRefGoogle ScholarPubMed
12.Hirano, A. Some current concepts of amyotrophic lateral sclerosis. Neurol Med (Tokyo) 1976; 4: 43–52.Google Scholar
13.Gajdusek, CD. Foci of motor neuron disease in high incidence in isolated populations of East Asia and the Western Pacific. In: Rowland, LP, ed. Human Motor Neuron Diseases. Advances in Neurology. New York: Raven Press 1982; 36: 363–393.Google Scholar
14.Rodgers-Johnson, P, Gamito, RM, Yanagihara, R, Chen, K-M, Gajdusek, DC, Gibbs, CJ. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: A 30-year evaluation of clinical and neuropathology. Trends in Neurology 1986; 36: 7–13.CrossRefGoogle Scholar
15.Anderson, FH, Richardson, EP Jr, Okazaki, H, Brody, JA. Neurofibrillary degeneration on Guam: Frequency in Chamorros and non chamorros with no known neurological disease. Brain 1979; 102: 65–77.CrossRefGoogle ScholarPubMed
16.Calne, DB. Personal communication.Google Scholar
17.Reed, D, Plato, C, Elizan, T, Kurland, LT. The amyotrophic lateral sclerosis/parkinsonism-dementia complex: A ten-year follow-up on Guam. Part I. Epidemiological studies. Amer J Epidemiol 1966; 83: 54–73.CrossRefGoogle Scholar
18.Reed, DM, Brody, JA. Amyotrophic lateral sclerosis and parkinsonismdementia on Guam, 1945–1972: 1. Descriptive epidemiology. Am J Epidemiol 1975; 101: 287–301.CrossRefGoogle Scholar
19.Kurland, LT, Molgaard, CA. Guamanian ALS: Hereditary or acquired? In: Rowland, LP, ed. Human Motor Neuron Diseases. Advances in Neurology. New York: Raven Press 1982; 36: 165–171.Google ScholarPubMed
20.Yanagihara, R, Gamito, RM, Gajdusek, DC, Tonita, A, Vchikawa, T, Konagaya, Y, Chen, K-M, Sobue, I, Plato, CC, Gibbs, CJ. Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia. Ann Neurol 1984; 15: 42–48.CrossRefGoogle ScholarPubMed
21. Gajdusek, DC, Salazar, AM. Amyotrophic lateral sclerosis and parkinsonian syndrome in high incidence among the Auyu and Jakai people of west New Guinea. Neurology 1982; 32: 107–126.CrossRefGoogle ScholarPubMed
22.Yoshimasu, F, Yasui, M, Yase, Y, et al. Studies on amyotrophic lateral sclerosis by neutron activation analysis. 3. Systematic analysis of metals on Guamanian ALS and PD cases. Folia Psychiat Neurol Jpn 1982; 36: 173–179.Google ScholarPubMed
23.Carpenter, S. Proximal axonal enlargement in motor neuron disease. Neurology 1968; 18: 841–851.CrossRefGoogle ScholarPubMed
24.Gamito, RM, Yanagihara, R, Gajdusek, DC. Disappearance of highincidence amyotrophic lateral sclerosis and parkinsonian-dementia on Guam. Neurology 1985; 35: 193–198.Google Scholar
25.Whiting, MG. Toxicity of cycads. Econ Bot 1963; 17: 271.CrossRefGoogle Scholar
26.O’Gara, RW, Brown, JM, Whiting, MG. Induction of hepatic and renal tumours by topical application of aqueous extract of the cycad nut to artificial skin ulcers in mice. Third Conference on the Toxicity of Cycads. Fed Proc 1964; 23: 1383.Google Scholar
27.Kurland, LT. An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam. Sixth international Cycad conference. Fed Proc 1972; 31: 1540–1542.Google Scholar
28.Hirano, A, Jones, M. Fine structure of cycasin-induced cerebellar alterations. Fed Proc 1972; 31: 1517–1519.Google ScholarPubMed
29.Kessler, A. Lathyrism. Monatsschr Psychiat Neurol 1947; 113: 76–92.Google ScholarPubMed
30.Spencer, PS, Schaumburg, HH, Cohn, DF, Seth, PK. Lathyrism: A useful model of primary lateral sclerosis. In: Rose, FC, ed. Research Progress in Motor Neurone Disease. Progress in Neurology Series. London. Pitman 1984; 312: 327.Google Scholar
31.Spencer, P, Nunn, P, Hugon, J, Ludolph, A, Ross, S, Roy, D, Schaumburg, H, Soiefera, A. Primate motor neuron disorders induced by chemically related excitatory neurotoxins isolated from Guamanian cycad and Indian chickling pea. Muscle & Nerve 1986; 9(supp. 5S): 108.Google Scholar
32.Spencer, PS, Ludolph, A, Dwivedi, MP, Dwijendra, NR, Hugon, J, Schaumburg, HH. Lathyrism: evidence for role of neuroexcitatory amino acid BOAA. Lancet 1986; 2: 1066–1067.CrossRefGoogle ScholarPubMed
33.Vega, A, Bell, EA. α-aminoβ-methylaminopropionic acid, a new amino acid from seeds of cycascircinalis. Phyto-chemistry 1967; 6: 759.Google Scholar
34.Spencer, PS, Nunn, PB, Hugon, J, Ludolph, A, Roy, DN. Motor neurone disease on Guam: Possible role of a food neurotoxin. Lancet 1986; 1: 965.CrossRefGoogle ScholarPubMed
35.Calne, DB, Eisen, A, McGeer, E, Spencer, P. Alzheimer’s disease, Parkinson’s disease, and Motoneurone disease: Abiotropic interaction between aging and environment? Lancet 1986; 2: 1067–1070.CrossRefGoogle Scholar
36.McComas, AJ, Upton, ARM, Sica, REP. Motoneurone disease and ageing. Lancet 1973; 2: 1477–1480.CrossRefGoogle ScholarPubMed
37.Gamito, RM, Gajdusek, DC, Chen, K-M. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann Neurol 1980; 8: 612–619.Google Scholar
38.McComas, AJ, Sica, REP, Campbell, MJ, Upton, ARM. Functional compensation in partially denervated muscles. J Neurol Neurosurg Psychiat 1971; 34: 453–460.CrossRefGoogle ScholarPubMed
39.Calne, DB, Langston, JW, Martin, WRW, Stoessl, AJ, Ruth, TJ, Adam, MJ, Pate, BD, Schulzer, M. Positron emission tomography after MPTP: Observations relating to the cause of Parkinson’s disease. Nature 1985; 317: 246–248.CrossRefGoogle Scholar